Treating individuals

	Summerskill W. Evidence-based practice and the individual. Lancet 2005;365:13-4
	Rothwell PM. 1. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005;365:82-93
	Rothwell PM. 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005;365:176-86
	Rothwell PM, Mehta Z, Howard SC, et al. 3. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet 2005;365:256-65
	Thompson SG, Higgins JP. 4. Can meta-analysis help target interventions at individuals most likely to benefit? Lancet 2005;365:341-6
	Jackson R, Lawes CM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005;365:434-41

Trials on trial

	Van Der Weyden MB. Trials on trial. Med J Aust  2001;175:241
	Gebski VJ, Beller EM, Keech AC. Randomised controlled trials: elements of a good study. Med J Aust 2001;175:272-274
	Ghersi D, Gebski VJ, Keech AC. Scientific background and rationale for a randomised controlled trial. Med J Aust 2001;175:386
	Keech AC, Gebski VJ. Selecting participants for clinical trials. Med J Aust 2001;175:490-1
	Brighton JK, Gebski VJ, Keech AC. Specifying interventions in a clinical trial.MJA 2002;176:281-282
	Kirby A, Gebski VJ Keech AC. Determining the sample size in a clinical trial. Med J Aust 2002;177:256-257
	Keech AC, Gebski V. Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects? Med J Aust 2002;177:445-7
	Gebski V, Marschner I, Keech AC. Specifying objectives and outcomes for clinical trials Med J Aust 2002;176:491-492
	Gebski VJ, Beller EM, Keech AC. Randomisation in clinical trials. Med J Aust 2002;177:565-567
	Gebski VJ, Beller EM, Keech AC. Statistical methods in clinical trials. Med J Aust 2003;178:182-184
	Cakir B, Gebski VJ, Keech AC. Flow of participants in randomised studies. MJA 2003;178:348-349
	Hague WE, Gebski VJ, Keech AC. Recruitment to randomised studies. Med J Aust 2003;178:579-581
	Burgess DC, Gebski VJ, Keech AC. Baseline data in clinical trials. MJA 2003;179:105-107
	Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust 2003;179:438-40
	O'Connell RL, Gebski VJ, Keech AC. Making sense of trial results: outcomes and estimation. Med J Aust 2004;180:128-30.
	Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Med J Aust 2004;180:289-291
	Simes RJ, Gebski VJ, Keech AC. Subgroup analysis: application to individual patient decisions. Med J Aust 2004;180:467-9
	Keech AC, Wonders SM, Cook DI, Gebski VJ. Balancing the outcomes: reporting adverse events. Med J Aust 2004;181:215-8
	Lord SJ, Gebski VJ, Keech AC. Multiple analyses in clinical trials: sound science or data dredging? Med J Aust 2004;181:452-4
	Seale JP, Gebski VJ, Keech AC. Generalising the results of trials to clinical practice. Med J Aust 2004;181:558-60
	Forder PM, Gebski VJ, Keech AC. Allocation concealment and blinding: when ignorance is bliss. Med J Aust 2005;182:87-9
	Wilcken NR, Gebski VJ, Pike R, et al. Putting results of a clinical trial into perspective. MJA 2007;186:368-370.
	Keech AC, Pike R, Granger RE, et al. Interpreting the results of a clinical trial. MJA 2007;186):318-319

Reliable assessment of the effects of treatment on mortality and major morbidity

	Collins R, McMahon S. I: Clinical Trials. Lancet 2001;357:373-80
	McMahon S, Collins R. II: Observational Studies. Lancet 2001;357:455-62.

Why randomized controlled trials fail but needn't

	Sackett DL, Hoey  J. Why randomized controlled trials fail but needn't: a new series is launched [editorial]. CMAJ 2000;162:1301-2
	Sackett DL. Failure to gain "coal-face" commitment and to use the uncertainty principle. CMAJ 2000;162:1311-4
	Sackett DL. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!) CMAJ 2001;165:1226-37.

Understanding controlled trials

	Sibbald B, Roland M. Why are randomized controlled trials important? BMJ 1998;316:201
	Roland M, Torgerson DJ.  What are pragmatic trials? BMJ 1998;316:285
	Torgerson DJ, Sibbald B. What is a patient preference trial? BMJ 1998;316:360
	Torgerson DJ, Roland M. What is Zelen's design? BMJ 1998;316:606
	Sibbald B, Roberts C. Crossover trials. BMJ 1998;316:1719-20
	Roberts C, Sibbald B. Randomising groups of patients BMJ 1998;316:1898
	Roland M, Torgerson D. What outcomes should be measured? BMJ 1998;317:1075
	Roberts C, Torgerson D. Randomisation methods in controlled trials.BMJ 1998;317:1301
	Roberts C, Torgerson D. Baseline imbalance in randomised controlled trials.BMJ 1999;319:185
	Roberts C, Torgerson D. Randomisation methods: concealment. BMJ 1999;319:375-6